A Mass Balance-Based Semiparametric Approach to Evaluate Neonatal Erythropoiesis

详细信息    查看全文

• 作者：Denison J. Kuruvilla ; John A. Widness ; Demet Nalbant ; Robert L. Schmidt…
• 关键词：anemic preterm infants ; neonatal erythropoiesis ; pharmacodynamic ; postnatal hemoglobin production ; very low birth weight
• 刊名：The AAPS Journal
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：18
• 期：1
• 页码：187-195
• 全文大小：500 KB
• 参考文献：1.Struss RG. Anaemia of prematurity: Pathophysiology and treatment. Blood Rev. 2010;24(6):221–5.CrossRef
  2.Kett JC. Anemia in infancy. Blood. 2012;1599:1678.
  3.Dallman PR. Anemia of prematurity. Annu Rev Med. 1981;32(1):143–60.PubMed CrossRef
  4.Finne P, Halvorsen S. Regulation of erythropoiesis in the fetus and newborn. Arch Dis Child. 1972;47(255):683.PubMed PubMedCentral CrossRef
  5.Kalpaktsoglou PK, Emery JL. The effect of birth on the haemopoietic tissue of the human bone marrow. A histological study. Br J Haematol. 1965;11(4):453–60.PubMed CrossRef
  6.Garby L, SjÖLin S, Vuille J-C. Studies on erythro-kinetics in infancy. Acta Pædiatrica. 1962;51(2):245–54.PubMed CrossRef
  7.Seip M. The reticulocyte level, and the erythrocyte production judged from reticulocyte studies, in newborn infants during the first week of life. Acta Paediatr. 1955;44(4):355–69.PubMed CrossRef
  8.Kett JC. Anemia in infancy. Pediatr Rev. 2012;33(4):186–7.PubMed CrossRef
  9.Kaplan E, Hsu KS. Determination of erythrocyte survival in newborn infants by means of Cr51-labelled erythrocytes. Pediatrics. 1961;27(3):354–61.PubMed
  10.Sturgeon P. Volumetric and microscopic pattern of bone marrow in normal infants and children: II Cytologic pattern. Pediatrics. 1951;7(5):642–50.PubMed
  11.Freise KJ, Widness JA, Veng-Pedersen P. Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants. J Pharmacol Exp Ther. 2010;332(1):229–37.PubMed PubMedCentral CrossRef
  12.Saleh MI, Nalbant D, Widness JA, Veng-Pedersen P. Population pharmacodynamic analysis of erythropoiesis in preterm infants for determining the anemia treatment potential of erythropoietin. Am J Physiol Regul Integr Comp Physiol. 2013;304(9):R772–81.PubMed PubMedCentral CrossRef
  13.Trudnowski RJ, Rico RC. Specific gravity of blood and plasma at 4 and 37°C. Clin Chem. 1974;20(5):615–6.PubMed
  14.Strauss RG. How I, transfuse red blood cells and platelets to infants with the anemia and thrombocytopenia of prematurity. Transfusion (Paris). 2008;48(2):209–17.CrossRef
  15.Krzyzanski W, Ramakrishnan R, Jusko W. Basic pharmacodynamic models for agents that alter production of natural cells. J Pharmacokinet Biopharm. 1999;27(5):467–89.PubMed CrossRef
  16.Pearson HA. Life-span of the fetal red blood cell. J Pediatr. 1967;70(2):166–71.PubMed CrossRef
  17.Brace RA, Langendörfer C, Song T-B, Mock DM. Red blood cell life span in the ovine fetus. Am J Physiol Regul, Integr Comp Physiol. 2000;279(4):R1196–204.
  18.Kuruvilla D, Widness J, Nalbant D, Schmidt R, Mock D, Veng-Pedersen P. A method to evaluate fetal erythropoiesis from postnatal survival of fetal RBCs. AAPS J. 2015;342:1–9.
  19.Mock DM, Widness JA, Veng-Pedersen P, Strauss RG, Cancelas JA, Cohen RM, et al. Measurement of posttransfusion red cell survival with the biotin label. Transfus Med Rev. 2014;28(3):114–25.PubMed PubMedCentral CrossRef
  20.Iman RL, Conover WJ. The use of the rank transform in regression. Technometrics. 1979;21(4):499–509.CrossRef
  21.Nelder JA, Mead R. A simplex method for function minimization. Comput J. 1965;7(4):308–13.CrossRef
  22.Reinsch C. Smoothing by spline functions. Numer Math. 1967;10(3):177–83.CrossRef
  23.R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014.
  24.Racine JS. RStudio: a platform-independent IDE for R and Sweave. J Appl Econ. 2012;27(1):167–72.CrossRef
  25.Veng-Pedersen P. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm. 1977;5(5):513–31.CrossRef
  26.Doyle JJ. The role of erythropoietin in the anemia of prematurity. Semin Perinatol. 1997;21(1):20–7.PubMed CrossRef
  27.Stockman III JA, Garcia JF, Oski FA. The anemia of prematurity: factors governing the erythropoietin response. N Engl J Med. 1977;296(12):647–50.PubMed CrossRef
  28.Hågå P, Meberg A, Halvorsen S. Plasma erythropoietin concentrations during the early anemia of prematurity. Acta Pædiatrica. 1983;72(6):827–31.CrossRef
  29.Krzyzanski W, Wyska E. Pharmacokinetics and pharmacodynamics of erythropoietin receptor in healthy volunteers. Naunyn-Schmied Arch Pharmacol. 2008;377(4–6):637–45.CrossRef
  30.Woo S, Krzyzanski W, Jusko W. Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO). J Pharmacokinet Pharmacodyn. 2007;34(6):849–68.PubMed CrossRef
  31.Arbuckle TE, Wilkins R, Sherman GJ. Birth weight percentiles by gestational age in Canada. Obstet Gynecol. 1993;81(1):39–48.PubMed
  
• 作者单位：Denison J. Kuruvilla (1)
  John A. Widness (2)
  Demet Nalbant (2)
  Robert L. Schmidt (2)
  Donald M. Mock (3)
  Peter Veng-Pedersen (1)
  
  1. Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, 115 S. Grand Ave. S227, Iowa City, Iowa, 52242, USA
  2. Department of Pediatrics, College of Medicine, University of Iowa, Iowa City, Iowa, USA
  3. Departments of Biochemistry & Molecular Biology and Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
  
• 刊物主题：Pharmacology/Toxicology; Biochemistry, general; Biotechnology; Pharmacy;
• 出版者：Springer US
• ISSN：1550-7416

文摘

Postnatal hemoglobin (Hb) production in anemic preterm infants is determined by several factors including the endogenous erythropoietin levels, allogeneic RBC transfusions administered to treat anemia, and developmental age. As a result, their postnatal Hb production rate can vary considerably. This work introduces a novel Hb mass balance-based semiparametric approach that utilizes infant blood concentrations of Hb from the first 30 postnatal days to estimate the amount of Hb produced and the erythropoiesis rate in newborn infants. The proposed method has the advantage of not relying on specific structural pharmacodynamic model assumptions to describe the Hb production, but instead utilizes simple mass balance principles and nonparametric regression analysis. The developed method was applied to the Hb data from 79 critically ill anemic very low birth weight preterm infants to evaluate the dynamic changes in erythropoiesis during the first month of life and to determine the inter-subject variability in Hb production. The estimated mean (±SD) cumulative amount of Hb produced by the infants over the first month of life was 6.6 ± 3.4 g (mean body weight, 0.768 kg), and the mean estimated body weight-scaled Hb production rate over the same period was 0.23 ± 0.12 g/day/kg. A significant positive correlation was observed between infant gestational age and the mean body weight-scaled Hb production rate over the first month of life (P < 0.05). We conclude that the proposed mathematical approach and its implementation provide a flexible framework to evaluate postnatal erythropoiesis in newborn infants. KEY WORDS anemic preterm infants neonatal erythropoiesis pharmacodynamic postnatal hemoglobin production very low birth weight